Joshua R. Disbrow - Jun 9, 2025 Form 4 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role
Chief Executive Officer
Signature
/s/ Joshua R. Disbrow
Stock symbol
AYTU
Transactions as of
Jun 9, 2025
Transactions value $
$99,999
Form type
4
Date filed
6/10/2025, 03:04 PM
Previous filing
May 16, 2025
Next filing
Oct 7, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Disbrow Joshua R. Chief Executive Officer C/O AYTU BIOPHARMA, INC., 7900 EAST UNION AVENUE, SUITE 920, DENVER /s/ Joshua R. Disbrow 2025-06-10 0001566240

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AYTU Common Stock Purchase $100K +66.7K +76.99% $1.50 153K Jun 9, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Purchased pursuant to the Issuer's registered offering more particularly described on the Registration Statement on Form S-1, as amended, filed by the Issuer on June 2, 2025.